论文信息 - Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome - 字舞流文

Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome

M. Chimenti | R. Scrivo | A. Picchianti Diamanti | B. Laganà | F. Conti | E. Greco | E. Molteni | A. Bergamini | G. Sciarra | Federico Bari,